• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当代急性冠状动脉综合征患者中,心肌梗死与出血严重程度对死亡率的预后影响差异

Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients.

作者信息

Caneiro-Queija Berenice, Abu-Assi Emad, Raposeiras-Roubín Sergio, Manzano-Fernández Sergio, Flores Blanco Pedro, López-Cuenca Ángel, Cobas-Paz Rafael, Gómez-Molina Miriam, Rodríguez-Rodríguez José Manuel, Calvo-Iglesias Francisco, Valdés-Chávarri Mariano, Íñiguez-Romo Andrés

机构信息

Servicio de Cardiología, Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain.

Servicio de Cardiología, Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain.

出版信息

Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):829-836. doi: 10.1016/j.rec.2018.02.008. Epub 2018 Apr 12.

DOI:10.1016/j.rec.2018.02.008
PMID:29656987
Abstract

INTRODUCTION AND OBJECTIVES

The impact on mortality of myocardial infarction (MI) compared with the specific degree of bleeding severity occurring after discharge in acute coronary syndrome is poorly characterized. Defining this relationship may help to achieve a favorable therapeutic risk-benefit balance.

METHODS

Using Cox-based shared frailty models, we assessed the relationship between mortality and postdischarge MI and bleeding severity-graded according to Bleeding Academic Research Consortium (BARC)-in 4229 acute coronary syndrome patients undergoing in-hospital coronary arteriography between January 2012 and December 2015.

RESULTS

Both MI (HR, 5.8; 95%CI, 3.7-9.8) and bleeding (HR, 5.1; 95%CI, 3.6-7.7) were associated with mortality. Myocardial infarction had a stronger impact on mortality than BARC type 2 and 3a bleedings: (RRr, 3.8 and 1.9; P < .05), respectively, but was equivalent to BARC type 3b (RRr, 0.9; P = .88). Mortality risk after MI was significantly lower than after BARC type 3c bleeding (RRr, 0.25; P < .001). Mortality was higher after an MI in patients on dual antiplatelet therapy (DAPT) at the time of the event (HR, 2.9; 95%CI, 1.8-4.5) than in those off-DAPT (HR, 1.5; 95%CI, 0.7-3.4). In contrast, mortality was lower after a bleeding event in patients on-DAPT (HR, 1.6; 95%CI, 1.1-2.6) than in those off-DAPT (HR, 3.2; 95%CI, 1.7-5.8).

CONCLUSIONS

The differential effect on mortality of a postdischarge MI vs bleeding largely depends on bleeding severity. The DAPT status at the time of MI or bleeding is a modifier of subsequent mortality risk.

摘要

引言与目的

急性冠状动脉综合征出院后发生的心肌梗死(MI)对死亡率的影响与特定出血严重程度的关系尚未得到充分描述。明确这种关系可能有助于实现良好的治疗风险效益平衡。

方法

我们使用基于Cox的共享脆弱模型,在2012年1月至2015年12月期间接受住院冠状动脉造影的4229例急性冠状动脉综合征患者中,评估死亡率与出院后心肌梗死及根据出血学术研究联盟(BARC)分级的出血严重程度之间的关系。

结果

心肌梗死(HR,5.8;95%CI,3.7 - 9.8)和出血(HR,5.1;95%CI,3.6 - 7.7)均与死亡率相关。心肌梗死对死亡率的影响比BARC 2型和3a型出血更强:分别为(RRr,3.8和1.9;P <.05),但与BARC 3b型相当(RRr,0.9;P = 0.88)。心肌梗死后的死亡风险显著低于BARC 3c型出血后(RRr,0.25;P <.001)。事件发生时接受双联抗血小板治疗(DAPT)的患者发生心肌梗死后的死亡率(HR,2.9;95%CI,1.8 - 4.5)高于未接受DAPT的患者(HR,1.5;95%CI,0.7 - 3.4)。相反,接受DAPT的患者发生出血事件后的死亡率(HR,1.6;95%CI,1.1 - 2.6)低于未接受DAPT者(HR,3.2;95%CI,1.7 - 5.8)。

结论

出院后心肌梗死与出血对死亡率的差异影响很大程度上取决于出血严重程度。心肌梗死或出血时的DAPT状态是后续死亡风险的一个调节因素。

相似文献

1
Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients.当代急性冠状动脉综合征患者中,心肌梗死与出血严重程度对死亡率的预后影响差异
Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):829-836. doi: 10.1016/j.rec.2018.02.008. Epub 2018 Apr 12.
2
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.急性冠状动脉综合征后心肌梗死与出血类型对死亡率的权衡:来自急性冠状动脉综合征临床事件减少凝血酶受体拮抗剂(TRACER)随机试验的经验教训。
Eur Heart J. 2017 Mar 14;38(11):804-810. doi: 10.1093/eurheartj/ehw525.
3
Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention.出血和心肌梗死对接受经皮冠状动脉介入治疗的所有患者死亡率的影响。
Circ Cardiovasc Interv. 2020 Sep;13(9):e009177. doi: 10.1161/CIRCINTERVENTIONS.120.009177. Epub 2020 Aug 25.
4
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.接受支架植入后 6 或 24 个月双抗血小板治疗的患者临床特征对缺血和出血结局的影响:来自 PRODIGY(评价支架内内膜增生后延长双联抗血小板治疗)试验的预先指定分析。
Eur Heart J. 2015 May 21;36(20):1242-51. doi: 10.1093/eurheartj/ehv038. Epub 2015 Feb 25.
5
Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation.药物洗脱支架置入后超过 1 年的双联抗血小板治疗时间的风险-获益特征与临床表现的关系。
Circ Cardiovasc Interv. 2019 Mar;12(3):e007541. doi: 10.1161/CIRCINTERVENTIONS.118.007541.
6
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.在采用当代药物洗脱支架和氯吡格雷或替格瑞洛治疗的急性冠脉综合征伴高出血风险患者中:来自 CHANGE DAPT 的研究结果。
Int J Cardiol. 2018 Oct 1;268:11-17. doi: 10.1016/j.ijcard.2018.03.116. Epub 2018 May 23.
7
A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.BRIC-ACS 研究:一种预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者出院后出血风险的评分。
Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1194-1204. doi: 10.1002/ccd.28325. Epub 2019 May 21.
8
Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.根据出血学术研究联盟分类的院内出血对接受经皮冠状动脉介入治疗患者长期不良结局的影响
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):63-71. doi: 10.1002/ccd.25308. Epub 2014 Jul 30.
9
The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications.出血学术研究联合会(BARC)定义的出血并发症对 ST 段抬高型心肌梗死的预后价值:与 TIMI(心肌梗死溶栓治疗)、GUSTO(全球应用链激酶和组织型纤溶酶原激活剂开通闭塞冠状动脉)和 ISTH(国际血栓与止血学会)出血分类的比较。
J Am Coll Cardiol. 2014 May 13;63(18):1866-75. doi: 10.1016/j.jacc.2014.01.069. Epub 2014 Mar 19.
10
Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.冠状动脉支架置入术后双联抗血小板治疗延长超过12个月的急性冠状动脉综合征患者的长期预后
Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1176-1184. doi: 10.1002/ccd.26831. Epub 2016 Nov 10.

引用本文的文献

1
Association of Ischemic and Bleeding Events With Mortality Among Patients in Sweden With Recent Acute Myocardial Infarction Receiving Antithrombotic Therapy.近期发生急性心肌梗死并接受抗血栓治疗的瑞典患者中,缺血性和出血性事件与死亡率的相关性。
JAMA Netw Open. 2022 Aug 1;5(8):e2220030. doi: 10.1001/jamanetworkopen.2022.20030.
2
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis.冠心病患者出血与心肌梗死的死亡率:系统评价和荟萃分析。
EuroIntervention. 2021 Sep 20;17(7):550-560. doi: 10.4244/EIJ-D-20-01197.
3
Incidence and prognostic impact of post discharge bleeding post acute coronary syndrome within an outpatient setting: a systematic review.
急性冠脉综合征出院后出血的发生率和预后影响:系统评价。
BMJ Open. 2019 Feb 20;9(2):e023337. doi: 10.1136/bmjopen-2018-023337.
4
Applicability of the PRECISE-DAPT score in elderly patients with myocardial infarction.PRECISE-DAPT评分在老年心肌梗死患者中的适用性。
J Geriatr Cardiol. 2018 Dec;15(12):713-717. doi: 10.11909/j.issn.1671-5411.2018.12.003.